DID WE FOCUS ON THE MOST IMPORTANT ISSUES IN THE USE OF GROWTH-FACTORS AND STEM-CELL TRANSPLANTATION

被引:13
作者
GULATI, SC
机构
关键词
D O I
10.1200/JCO.1994.12.4.650
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:650 / 652
页数:3
相关论文
共 26 条
[1]  
Bender J G, 1992, J Hematother, V1, P329, DOI 10.1089/scd.1.1992.1.329
[2]  
BONEWALD LF, 1992, EXP HEMATOL, V20, P1249
[3]   GENE-MARKING TO TRACE ORIGIN OF RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
BRENNER, MK ;
RILL, DR ;
MOEN, RC ;
KRANCE, RA ;
MIRRO, J ;
ANDERSON, WF ;
IHLE, JN .
LANCET, 1993, 341 (8837) :85-86
[4]  
BRUGGER W, 1992, BLOOD, V79, P1193
[5]   CONSENSUS CONFERENCE ON INTENSIVE CHEMOTHERAPY PLUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN MALIGNANCIES - LYON, FRANCE, JUNE 4-6, 1993 [J].
COIFFIER, B ;
PHILIP, T ;
BURNETT, AK ;
SYMANN, ML .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :226-231
[6]  
COUTINHO LH, 1990, BLOOD, V75, P2118
[7]   USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR BEFORE, DURING, AND AFTER FLUDARABINE PLUS CYTARABINE INDUCTION THERAPY OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROMES - COMPARISON WITH FLUDARABINE PLUS CYTARABINE WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR [J].
ESTEY, E ;
THALL, P ;
ANDREEFF, M ;
BERAN, M ;
KANTARJIAN, H ;
OBRIEN, S ;
ESCUDIER, S ;
ROBERTSON, LE ;
KOLLER, C ;
KORNBLAU, S ;
PIERCE, S ;
FREIREICH, E ;
DEISSEROTH, A ;
KEATING, M .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :671-678
[8]   IMMUNOLOGICAL PURGING OF MARROW ASSESSED BY PCR BEFORE AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR B-CELL LYMPHOMA [J].
GRIBBEN, JG ;
FREEDMAN, AS ;
NEUBERG, D ;
ROY, DC ;
BLAKE, KW ;
WOO, SD ;
GROSSBARD, ML ;
RABINOWE, SN ;
CORAL, F ;
FREEMAN, GJ ;
RITZ, J ;
NADLER, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (22) :1525-1533
[9]   GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS ADJUNCT THERAPY IN RELAPSED HODGKIN DISEASE [J].
GULATI, SC ;
BENNETT, CL .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (03) :177-182
[10]  
GULATI SC, 1993, PURGING BONE MARROW